Another perplexing case of a patient suffering liver injury.
This report discusses use of desiccated thyroid and liothyronine.
Again the suggestion that the problem is hapten-based.
Liver Injury Induced by Levothyroxine in a Patient with Primary Hypothyroidism
Tomotaka Kawakami1, Atsushi Tanaka1, Shinichiro Negoro1, Yoshihiko Morisawa1, Masaki Mikami1, Makoto Hojo1, Takatsugu Yamamoto1, Satoko Uegaki1, Mitsuhiko Aiso1, Takahiro Kawasaki1, Taro Ishii1, Yasushi Kuyama1, Toshio Fukusato2 and Hajime Takikawa1
Abstract
We report a patient with primary hypothyroidism, who developed hepatocellular injury due to levothyroxine, synthetic thyroxine. A 63-year-old male was admitted to our hospital due to elevation of liver enzymes. The patient was diagnosed as having hypothyroidism and had been treated with levothyroxine for almost two months until admission. Drug-induced liver injury induced due to levothyroxine was suspected and liver enzymes were rapidly decreased after discontinuation of levothyroxine and dried thyroid powder, also containing thyroxine. Synthetic triiodothyronine, the deiodinated form of levothyroxine was administered instead, and was well tolerated by the patient. The drug-induced lymphocyte stimulation test (DLST) using levothyroxine was negative. Since triiodothyronine which structurally resembles levothyroxine did not cause liver injury, and DLST using levothyroxine was negative, it is unlikely that levothyroxine itself was targeted by the immune system. Rather, we assume that the complex of levothyroxine as the hapten and liver-related macromolecules in the body as the carrier might have acquired antigenecity in this patient and subsequently resulted in liver injury.
Key words: levothyroxine, drug-induced liver injury (DOI: 10.2169/internalmedicine.46.0086)
Open access here:
jstage.jst.go.jp/article/in...
See also these other posts here:
Liver injury induced by levothyroxine tablets in a patient with hypothyroidism
healthunlocked.com/thyroidu...
Occurrence of thyroxine tablet (Thyradin S(®)) - induced liver dysfunction in a patient with subclinical hypothyroidism.